WallStreetZenWallStreetZen

NASDAQ: VRDN
Viridian Therapeutics Inc Stock Ownership - Who owns Viridian Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Viridian Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas W. BeethamChief Operating Officer2024-09-275,000$23.41
$117.05kBuy
Stephen F. MahoneyPresident and CEO2024-09-2721,400$23.33
$499.26kBuy
Fairmount Funds Management LLCDirector2024-09-131,600,000$18.75
$30.00MBuy

1 of 1

VRDN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRDN insiders and whales buy or sell their stock.

VRDN Shareholders

What type of owners hold Viridian Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.58%11,881,912$181.32MInstitution
Logos Global Master Fund LP7.36%6,000,000$91.56MInsider
Blackrock Inc7.07%5,758,577$87.88MInstitution
Vanguard Group Inc5.64%4,595,049$70.12MInstitution
Deep Track Capital LP5.55%4,522,741$69.02MInstitution
Fairmount Funds Management LLC4.87%3,972,206$60.62MInsider
Vr Adviser LLC4.76%3,882,709$59.25MInstitution
State Street Corp4.32%3,522,566$53.75MInstitution
Fairmount Funds Management LLC4.23%3,445,813$52.58MInstitution
Kynam Capital Management LP4.08%3,326,262$50.76MInstitution

1 of 3

VRDN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRDN74.82%25.18%Net Buying
ETNB83.07%11.13%Net BuyingNet Buying
ADPT61.67%38.33%Net SellingNet Selling
ARDX40.12%59.88%Net BuyingNet Buying
NVAX63.79%17.24%Net SellingNet Selling
View Top Biotech Stocks

Viridian Therapeutics Stock Ownership FAQ

Who owns Viridian Therapeutics?

Viridian Therapeutics (NASDAQ: VRDN) is owned by 111.73% institutional shareholders, 37.60% Viridian Therapeutics insiders, and 0.00% retail investors. Logos Global Master Fund LP is the largest individual Viridian Therapeutics shareholder, owning 6.00M shares representing 7.36% of the company. Logos Global Master Fund LP's Viridian Therapeutics shares are currently valued at $91.56M.

If you're new to stock investing, here's how to buy Viridian Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.